[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Memory Impairment Treatment Market Report 2018

January 2018 | 100 pages | ID: UE7218396E5EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Memory Impairment Treatment market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Memory Impairment Treatment in these regions, from 2013 to 2025 (forecast).
United States Memory Impairment Treatment market competition by top manufacturers/players, with Memory Impairment Treatment sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • F. Hoffmann-La Roche Ltd.
  • Suven Life Sciences Ltd.
  • Met P Pharma AG
  • Dart NeuroScience LLC.
  • Omeros Corporation
  • Sunovion Pharmaceuticals Inc.
  • AbbVie Inc.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • HT-3951
  • 2-PMPA
  • Meldonium
  • AC-253
  • RO-4938581
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Clinic
  • Hospital
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Memory Impairment Treatment Market Report 2018

1 MEMORY IMPAIRMENT TREATMENT OVERVIEW

1.1 Product Overview and Scope of Memory Impairment Treatment
1.2 Classification of Memory Impairment Treatment by Product Category
  1.2.1 United States Memory Impairment Treatment Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Memory Impairment Treatment Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 HT-3951
  1.2.4 2-PMPA
  1.2.5 Meldonium
  1.2.6 AC-253
  1.2.7 RO-4938581
  1.2.8 Others
1.3 United States Memory Impairment Treatment Market by Application/End Users
  1.3.1 United States Memory Impairment Treatment Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Clinic
  1.3.3 Hospital
  1.3.4 Others
1.4 United States Memory Impairment Treatment Market by Region
  1.4.1 United States Memory Impairment Treatment Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Memory Impairment Treatment Status and Prospect (2013-2025)
  1.4.3 Southwest Memory Impairment Treatment Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Memory Impairment Treatment Status and Prospect (2013-2025)
  1.4.5 New England Memory Impairment Treatment Status and Prospect (2013-2025)
  1.4.6 The South Memory Impairment Treatment Status and Prospect (2013-2025)
  1.4.7 The Midwest Memory Impairment Treatment Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Memory Impairment Treatment (2013-2025)
  1.5.1 United States Memory Impairment Treatment Sales and Growth Rate (2013-2025)
  1.5.2 United States Memory Impairment Treatment Revenue and Growth Rate (2013-2025)

2 UNITED STATES MEMORY IMPAIRMENT TREATMENT MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Memory Impairment Treatment Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Memory Impairment Treatment Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Memory Impairment Treatment Average Price by Players/Suppliers (2013-2018)
2.4 United States Memory Impairment Treatment Market Competitive Situation and Trends
  2.4.1 United States Memory Impairment Treatment Market Concentration Rate
  2.4.2 United States Memory Impairment Treatment Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Memory Impairment Treatment Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES MEMORY IMPAIRMENT TREATMENT SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Memory Impairment Treatment Sales and Market Share by Region (2013-2018)
3.2 United States Memory Impairment Treatment Revenue and Market Share by Region (2013-2018)
3.3 United States Memory Impairment Treatment Price by Region (2013-2018)

4 UNITED STATES MEMORY IMPAIRMENT TREATMENT SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Memory Impairment Treatment Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Memory Impairment Treatment Revenue and Market Share by Type (2013-2018)
4.3 United States Memory Impairment Treatment Price by Type (2013-2018)
4.4 United States Memory Impairment Treatment Sales Growth Rate by Type (2013-2018)

5 UNITED STATES MEMORY IMPAIRMENT TREATMENT SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Memory Impairment Treatment Sales and Market Share by Application (2013-2018)
5.2 United States Memory Impairment Treatment Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES MEMORY IMPAIRMENT TREATMENT PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 F. Hoffmann-La Roche Ltd.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Memory Impairment Treatment Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 F. Hoffmann-La Roche Ltd. Memory Impairment Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Suven Life Sciences Ltd.
  6.2.2 Memory Impairment Treatment Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Suven Life Sciences Ltd. Memory Impairment Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Met P Pharma AG
  6.3.2 Memory Impairment Treatment Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Met P Pharma AG Memory Impairment Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Dart NeuroScience LLC.
  6.4.2 Memory Impairment Treatment Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Dart NeuroScience LLC. Memory Impairment Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Omeros Corporation
  6.5.2 Memory Impairment Treatment Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Omeros Corporation Memory Impairment Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Sunovion Pharmaceuticals Inc.
  6.6.2 Memory Impairment Treatment Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Sunovion Pharmaceuticals Inc. Memory Impairment Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 AbbVie Inc.
  6.7.2 Memory Impairment Treatment Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 AbbVie Inc. Memory Impairment Treatment Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview

7 MEMORY IMPAIRMENT TREATMENT MANUFACTURING COST ANALYSIS

7.1 Memory Impairment Treatment Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Memory Impairment Treatment

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Memory Impairment Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Memory Impairment Treatment Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES MEMORY IMPAIRMENT TREATMENT MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Memory Impairment Treatment Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Memory Impairment Treatment Sales Volume Forecast by Type (2018-2025)
11.3 United States Memory Impairment Treatment Sales Volume Forecast by Application (2018-2025)
11.4 United States Memory Impairment Treatment Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Memory Impairment Treatment
Figure United States Memory Impairment Treatment Market Size (K Pcs) by Type (2013-2025)
Figure United States Memory Impairment Treatment Sales Volume Market Share by Type (Product Category) in 2017
Figure HT-3951 Product Picture
Figure 2-PMPA Product Picture
Figure Meldonium Product Picture
Figure AC-253 Product Picture
Figure RO-4938581 Product Picture
Figure Others Product Picture
Figure United States Memory Impairment Treatment Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Memory Impairment Treatment by Application in 2017
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Memory Impairment Treatment Market Size (Million USD) by Region (2013-2025)
Figure The West Memory Impairment Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Memory Impairment Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Memory Impairment Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Memory Impairment Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Memory Impairment Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Memory Impairment Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Memory Impairment Treatment Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Memory Impairment Treatment Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Memory Impairment Treatment Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Memory Impairment Treatment Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Memory Impairment Treatment Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Memory Impairment Treatment Sales Share by Players/Suppliers
Figure 2017 United States Memory Impairment Treatment Sales Share by Players/Suppliers
Figure United States Memory Impairment Treatment Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Memory Impairment Treatment Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Memory Impairment Treatment Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Memory Impairment Treatment Revenue Share by Players/Suppliers
Figure 2017 United States Memory Impairment Treatment Revenue Share by Players/Suppliers
Table United States Market Memory Impairment Treatment Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Memory Impairment Treatment Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Memory Impairment Treatment Market Share of Top 3 Players/Suppliers
Figure United States Memory Impairment Treatment Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Memory Impairment Treatment Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Memory Impairment Treatment Product Category
Table United States Memory Impairment Treatment Sales (K Pcs) by Region (2013-2018)
Table United States Memory Impairment Treatment Sales Share by Region (2013-2018)
Figure United States Memory Impairment Treatment Sales Share by Region (2013-2018)
Figure United States Memory Impairment Treatment Sales Market Share by Region in 2017
Table United States Memory Impairment Treatment Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Memory Impairment Treatment Revenue Share by Region (2013-2018)
Figure United States Memory Impairment Treatment Revenue Market Share by Region (2013-2018)
Figure United States Memory Impairment Treatment Revenue Market Share by Region in 2017
Table United States Memory Impairment Treatment Price (USD/Pcs) by Region (2013-2018)
Table United States Memory Impairment Treatment Sales (K Pcs) by Type (2013-2018)
Table United States Memory Impairment Treatment Sales Share by Type (2013-2018)
Figure United States Memory Impairment Treatment Sales Share by Type (2013-2018)
Figure United States Memory Impairment Treatment Sales Market Share by Type in 2017
Table United States Memory Impairment Treatment Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Memory Impairment Treatment Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Memory Impairment Treatment by Type (2013-2018)
Figure Revenue Market Share of Memory Impairment Treatment by Type in 2017
Table United States Memory Impairment Treatment Price (USD/Pcs) by Types (2013-2018)
Figure United States Memory Impairment Treatment Sales Growth Rate by Type (2013-2018)
Table United States Memory Impairment Treatment Sales (K Pcs) by Application (2013-2018)
Table United States Memory Impairment Treatment Sales Market Share by Application (2013-2018)
Figure United States Memory Impairment Treatment Sales Market Share by Application (2013-2018)
Figure United States Memory Impairment Treatment Sales Market Share by Application in 2017
Table United States Memory Impairment Treatment Sales Growth Rate by Application (2013-2018)
Figure United States Memory Impairment Treatment Sales Growth Rate by Application (2013-2018)
Table F. Hoffmann-La Roche Ltd. Basic Information List
Table F. Hoffmann-La Roche Ltd. Memory Impairment Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure F. Hoffmann-La Roche Ltd. Memory Impairment Treatment Sales Growth Rate (2013-2018)
Figure F. Hoffmann-La Roche Ltd. Memory Impairment Treatment Sales Market Share in United States (2013-2018)
Figure F. Hoffmann-La Roche Ltd. Memory Impairment Treatment Revenue Market Share in United States (2013-2018)
Table Suven Life Sciences Ltd. Basic Information List
Table Suven Life Sciences Ltd. Memory Impairment Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Suven Life Sciences Ltd. Memory Impairment Treatment Sales Growth Rate (2013-2018)
Figure Suven Life Sciences Ltd. Memory Impairment Treatment Sales Market Share in United States (2013-2018)
Figure Suven Life Sciences Ltd. Memory Impairment Treatment Revenue Market Share in United States (2013-2018)
Table Met P Pharma AG Basic Information List
Table Met P Pharma AG Memory Impairment Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Met P Pharma AG Memory Impairment Treatment Sales Growth Rate (2013-2018)
Figure Met P Pharma AG Memory Impairment Treatment Sales Market Share in United States (2013-2018)
Figure Met P Pharma AG Memory Impairment Treatment Revenue Market Share in United States (2013-2018)
Table Dart NeuroScience LLC. Basic Information List
Table Dart NeuroScience LLC. Memory Impairment Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Dart NeuroScience LLC. Memory Impairment Treatment Sales Growth Rate (2013-2018)
Figure Dart NeuroScience LLC. Memory Impairment Treatment Sales Market Share in United States (2013-2018)
Figure Dart NeuroScience LLC. Memory Impairment Treatment Revenue Market Share in United States (2013-2018)
Table Omeros Corporation Basic Information List
Table Omeros Corporation Memory Impairment Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Omeros Corporation Memory Impairment Treatment Sales Growth Rate (2013-2018)
Figure Omeros Corporation Memory Impairment Treatment Sales Market Share in United States (2013-2018)
Figure Omeros Corporation Memory Impairment Treatment Revenue Market Share in United States (2013-2018)
Table Sunovion Pharmaceuticals Inc. Basic Information List
Table Sunovion Pharmaceuticals Inc. Memory Impairment Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Sunovion Pharmaceuticals Inc. Memory Impairment Treatment Sales Growth Rate (2013-2018)
Figure Sunovion Pharmaceuticals Inc. Memory Impairment Treatment Sales Market Share in United States (2013-2018)
Figure Sunovion Pharmaceuticals Inc. Memory Impairment Treatment Revenue Market Share in United States (2013-2018)
Table AbbVie Inc. Basic Information List
Table AbbVie Inc. Memory Impairment Treatment Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure AbbVie Inc. Memory Impairment Treatment Sales Growth Rate (2013-2018)
Figure AbbVie Inc. Memory Impairment Treatment Sales Market Share in United States (2013-2018)
Figure AbbVie Inc. Memory Impairment Treatment Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Memory Impairment Treatment
Figure Manufacturing Process Analysis of Memory Impairment Treatment
Figure Memory Impairment Treatment Industrial Chain Analysis
Table Raw Materials Sources of Memory Impairment Treatment Major Players/Suppliers in 2017
Table Major Buyers of Memory Impairment Treatment
Table Distributors/Traders List
Figure United States Memory Impairment Treatment Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Memory Impairment Treatment Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Memory Impairment Treatment Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Memory Impairment Treatment Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Memory Impairment Treatment Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Memory Impairment Treatment Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Memory Impairment Treatment Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Memory Impairment Treatment Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Memory Impairment Treatment Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Memory Impairment Treatment Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Memory Impairment Treatment Sales Volume Share Forecast by Region (2018-2025)
Figure United States Memory Impairment Treatment Sales Volume Share Forecast by Region (2018-2025)
Figure United States Memory Impairment Treatment Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories